Clinical PDF Library · product and regimen proof

Eleven clinical PDFs, built to be used.

Choose a product or result first. Each download keeps the number, timing, method, tested article, and source context together—eight core studies plus three complete EyeCrème and NeoTight reports.

11direct clinical PDF downloads
08core product and regimen studies
03complete eye-area reports

Choose the proof you want to keep

Each card leads with the result people ask about most. Download the PDF to keep the visual brief and source pages, or open the online report for the full result.

SenePlex+ Normal-to-Dry DayTime Moisturizer

Report + selected laboratory source · 8 pages

SenePlex+ Normal-to-Dry Regimen — Eight-Week Skin Quality

23.60%mean visible-radiance improvement at week 8

Independent testing measured hydration, firmness, visible radiance, texture, tone evenness, fine-line appearance, and participant perception through eight weeks. Mean visible radiance improved 23.60% at week eight, and 96.88% of participants achieved visible improvement on that endpoint.

SenePlex+ Evening Moisturizer Normal to Dry

Study brief + preliminary laboratory summary · 3 pages

SenePlex+ Evening Moisturizer — Surface Renewal

up to 100% greatervisible surface-cell turnover than untreated skin by day 18

In an independent 20-day study, a tested SenePlex+ Evening Moisturizer formula showed up to 100% greater visible surface-cell turnover than untreated skin by day 18. Dansyl-chloride scoring documented mean residual surface-stain intensity of 0.00 treated versus 0.18 untreated at day 18; lower values indicate faster clearance.

SeneCell SenePlex+ StemCell Concentrate

Study brief + preliminary laboratory summary · 2 pages

SeneCell Hydration

56.4%mean measured-hydration improvement at week 8

Measured hydration improved 73.9% immediately, 42.5% at 24 hours, 32.5% at 48 hours, 22.1% at four weeks, and 56.4% at eight weeks; every timepoint was p<0.001. All participants improved immediately and at eight weeks, and no irritation was observed.

GLP Complex with SenePlex+ and Exosomes

Study brief + preliminary laboratory summary · 3 pages

GLP Complex Wrinkles and Facial Volume

23.4%mean deep-wrinkle appearance improvement at week 8

Finished-product image analysis measured an 11.2% reduction in deep-wrinkle appearance at four weeks and 23.4% at eight weeks, with all 31 participants improving at both points. Facial-volume appearance improved 8.4% at eight weeks, when 81% improved.

NeoTight Rejuvenating elasticity result

Report + laboratory source · 23 pages

NeoTight Rejuvenating Anti-Wrinkle Serum

7.65%measured net-elasticity improvement after one hour

Independent one-hour and six-week instrumental, expert-graded, and participant-perception results, including a 7.65% improvement in measured net skin elasticity one hour after one application.

C-Bright eight-week brightness results

Report + preliminary laboratory source · 6 pages

C-Bright Dark Spot Corrector

88%participants improving in brightness at week 8

Eight-week image analysis covers brightness, hyperpigmentation, dark-acne-scar appearance, and skin tone. Responder results include 76% for brightness at four weeks, 88% at eight weeks, 77% for dark-acne-scar appearance, and 85% for the L* skin-tone endpoint at eight weeks.

Current EyeCrème

Current official evidence brief · 2 pages

EyeCrème Clinical, Consumer, and Safety Results

87.10%participants with measured radiance improvement at week 8

In an eight-week independent clinical study of EyeCrème, 87.10% of participants showed measured improvement in eye-area skin radiance and 64.52% showed a measured decrease in eye-area wrinkle appearance. Companion consumer findings and ophthalmologist-tested reassurance complete the current product record.

LipSense Cream clinical evaluation scales

Clinical evaluation + signed laboratory source · 16 pages

LipSense Cream

3.2 / 3.4technician / participant appearance means at 4 hours

At four hours, mean LipSense® Cream (formerly HydraMatte) appearance scores were 3.2 by trained-technician assessment and 3.4 by participant assessment on the study's 0-to-4 scale. The same study also measured transfer and brief water-exposure performance.

What the package label tells you

The library brings eight core studies and three complete eye-area reports into one download collection, with each package labeled for the depth of study documentation it contains.

Report + sourceA designed clinical report followed by selected or complete independent laboratory documentation.
Study brief + laboratory summaryA formula-specific evidence brief followed by the laboratory summary. When a source is preliminary, the card and PDF preserve that status.
Official evidence briefA concise brief drawn from the official US product record. Use the full eye-area reports below when you want complete study and source detail.

Complete eye-area reports · product, results, source

Three full reports on eye-area safety and visible results

EyeCrème and NeoTight each do a different job. Explore the result, timing, method, exact tested article, and laboratory source for each, then choose the report that matches your eye-area question.

Complete six-week report · 24 pages

NeoTight Eye Serum

Tested article: NeoTight Revitalizing Eye Serum · sample SA211001 · CS201061 / RE201061.V01 · source file SGF20117-01

At six weeks: 38.10% mean improvement in dark-circle appearance, 23.12% in puffiness and bags, and 8.82% in peri-orbital fine-line appearance. Current SKU 3392 packaging retains the Revitalizing Eye Serum name, and SeneGence's January 2026 catalogue republishes this study's rounded results.

Complete eight-week efficacy report · 17 pages

EyeCrème Efficacy

Tested article: EyeCrème SA221009 / SGF19112-03 · CS211048 / RE211048.V02

At eight weeks: 20.21% mean improvement in eye-area radiance and 9.15% in crow's-feet appearance. SeneGence continues to publish this report's distinctive 31-participant result family for current EyeCrème.

Complete ophthalmologic safety report · 18 pages

EyeCrème Safety

Tested article: Eye Creme AGE Defense Formula SGF19112-03 · Essex Panel 21663 / Entry 46915

Thirty participants completed the two-week study, including eight contact-lens wearers, with zero test-article-related adverse effects under the reported conditions.

from result to current product

Continue with the products these studies tested

Each result belongs to the product or regimen it was measured on. Open the one that matches what you came to find out.